Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multistep and multifactorial carcinogenesis: when does a contributing factor become a carcinogen?

Michele Carbone1, Harvey I Pass

  • 1Department of Pathology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Room 250, 2160 South First Ave, Maywood, IL 60302, USA. mcarbon@lumc.edu

Seminars in Cancer Biology
|October 19, 2004
PubMed
Summary

Identifying cancer-causing agents early is crucial for prevention. This study proposes molecular criteria to identify human carcinogens before widespread disease occurs, aiding proactive cancer control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant.

Nature·2026
Same author

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma.

The Annals of thoracic surgery·2026
Same author

LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer.

Cancer discovery·2026
Same author

Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Publisher Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant.

Nature·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Carcinogenesis Research

Background:

  • Cancer treatment successes are limited compared to prevention via removing carcinogens and pre-malignant lesions.
  • Current epidemiological studies identify carcinogens only after significant cancer development.
  • Understanding molecular pathways of cancer is key to early carcinogen identification.

Purpose of the Study:

  • To review molecular changes required for carcinogenesis.
  • To propose criteria for identifying human carcinogens in the absence of epidemiological data.
  • To shift focus towards early detection and removal of cancer-initiating agents.

Main Methods:

  • Review of molecular pathways involved in cancer development.
  • Proposal of criteria for identifying carcinogens based on animal studies, cell transformation, and molecular evidence.

Related Experiment Videos

  • Analysis of molecular interference with key pathways in human cells.

    • Main Results:

    • Established criteria for identifying human carcinogens without epidemiological evidence.
    • Criteria include: (1) tumor development in animals, (2) human cell transformation, and (3) molecular pathway interference.
    • Highlights the importance of targeting initiators, co-carcinogens, and promoters.

    Conclusions:

    • Early identification and removal of carcinogens are more effective than treating established malignancies.
    • Proposed molecular criteria can identify potential human carcinogens proactively.
    • Applying molecular knowledge to carcinogen identification is essential for cancer prevention.